|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.215 USD | +1.61% |
|
+7.00% | -58.75% |
| 06-29 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark | CI |
| 06-28 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 393M | - | - | - | - | - |
| 56.21B | |||||
| 55.38B | |||||
| 23.75B | - | ||||
| 23.19B | - | ||||
| 18.14B |
Select your edition
All financial news and data tailored to specific country editions
